Soleno Therapeutics's total assets for Q3 2025 were $599.89M, an increase of 80.52% from the previous quarter. SLNO total liabilities were $105.09M for the fiscal quarter, a 14.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.